Table 5.
Cancer Center Accrual to Cooperative Group Trials and Non-Cooperative Group Trials
| Cancer Center | Cancer Center | Cancer Center | Cancer Center | ||
|---|---|---|---|---|---|
| Accruals By Sponsor: | A | B | C | D | Overall |
| Time Period | 1/2001-7/2005 | 1/2000-9/2006 | 1/2000- 12/2005 | 1/2000-4/2007 | |
| Cooperative Group Trials | |||||
| n= | 37 | 166 | 61 | 130 | 394 |
| zero | 27.0% | 38.6% | 29.5% | 46.9% | 38.8% |
| 1-4 | 37.8% | 38.6% | 39.3% | 38.5% | 38.6% |
| 5-10 | 13.5% | 13.9% | 19.7% | 7.7% | 12.7% |
| 11-15 | 8.1% | 4.2% | 6.6% | 0.0% | 3.6% |
| 16-20 | 2.7% | 0.0% | 1.6% | 4.6% | 2.0% |
| >20 | 10.8% | 4.8% | 3.3% | 2.3% | 4.3% |
|
| |||||
| Non-Cooperative Group Trials | |||||
| n= | 111 | 157 | 43 | 193 | 504 |
| zero | 18.9% | 14.6% | 23.3% | 25.9% | 20.6% |
| 1-4 | 30.6% | 22.9% | 9.3% | 26.4% | 24.8% |
| 5-10 | 23.4% | 18.5% | 32.6% | 24.9% | 23.2% |
| 11-15 | 12.6% | 13.4% | 14.0% | 7.3% | 10.9% |
| 16-20 | 2.7% | 7.6% | 7.0% | 5.7% | 5.8% |
| >20 | 11.7% | 22.9% | 14.0% | 9.8% | 14.7% |